Profits Before People?: Ethical Standards and the Marketing of Prescription Drugs

Profits Before People?: Ethical Standards and the Marketing of Prescription Drugs

by Leonard J. Weber
     
 

ISBN-10: 0253347483

ISBN-13: 9780253347480

Pub. Date: 04/28/2006

Publisher: Indiana University Press

The pharmaceutical industry has come under intense criticism in recent years. One poll found that 70% of the sample agreed that drug companies put profits ahead of people. Is this perception accurate? Have drug companies traded ethics for profits and placed people at risk?

In Profits before People? Leonard J. Weber exposes pharmaceutical industry practices

…  See more details below

Overview

The pharmaceutical industry has come under intense criticism in recent years. One poll found that 70% of the sample agreed that drug companies put profits ahead of people. Is this perception accurate? Have drug companies traded ethics for profits and placed people at risk?

In Profits before People? Leonard J. Weber exposes pharmaceutical industry practices that have raised ethical concerns. Providing systematic ethical analysis and reflection, he discusses such practices as compensating physicians for serving as speakers or consultants, providing incentives to physicians to enroll patients as subjects in clinical research, and advertising prescription drugs to the public through the mass media. Weber’s critique of the industry is stern. While acknowledging that new industry guidelines are promising, he finds much room for improvement in the way drug companies market their products. Yet Weber makes a strong case that profits and ethics can coexist and that they are not mutually exclusive.

In an effort to understand the proper place of commerce in disseminating information about new drugs, the book aims to clarify basic responsibilities and to help identify sound ethical practices. It recognizes that ethics and law are not the same, that "having a right" is different from "doing the right thing," and that taking ethics seriously means recognizing that the law does not answer all questions about what is right. Weber points the way to more demanding standards and better practices that might begin to restore confidence in the drug industry.

Indiana University Press

Read More

Product Details

ISBN-13:
9780253347480
Publisher:
Indiana University Press
Publication date:
04/28/2006
Series:
Bioethics and the Humanities Series
Pages:
224
Product dimensions:
6.12(w) x 9.25(h) x 0.73(d)

Related Subjects

Table of Contents

Contents
Acknowledgments

Introduction
I. The Limits of Commercial Interests
1. Ethics and For-Profit Business
2. The Pharmaceutical Industry and Its Stakeholders
II. Marketing to Healthcare Professionals
3. Drug Companies and Healthcare Professionals: The Ethics Agenda
4. Medical Professionalism and Scientific Integrity
5. The Industry's Code: Not Good Enough
6. Drug Samples: The Most Important Gifts
7. Marketing Is Not Objective Education
8. Medical Education: Industry at Arm's Length
9. Clinical Research and the Limits of Commercial Interests
III. Marketing to the Public
10. Citizens and Consumers
11. Direct-to-Consumer Advertising: Conflicting Interests
12. Direct-to-Consumer Advertising: Better Is Better
Conclusion

Notes
Index

Indiana University Press

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >